Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cellsin vitro-Reference-Cited by-同舟云学术

Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cellsin vitro

Published:2003-06-16 Issue:1 Volume:59 Page:115-128
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Florio Tullio,Thellung Stefano,Corsaro Alessandro,Bocca Liliana,Arena Sara,Pattarozzi Alessandra,Villa Valentina,Massa Alessandro,Diana Fabrizio,Schettini Daria,Barbieri Federica,Ravetti Jean Louis,Spaziante Renato,Giusti Massimo,Schettini Gennaro

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2265.2003.01811.x/fullpdf

Reference53 articles.

1. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre;Abe;European Journal of Endocrinology,2001

2. Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg);Baldelli;Journal of Clinical Endocrinology and Metabolism,2000

3. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro;Billestrup;Proceedings of the National Academy of Sciences of the USA,1986

4. sst2 somatostatin receptor mediates negative regulation of insulin receptor signalling through the tyrosine phosphatase SHP-1;Bousquet;Journal of Biology Chemistry,1998

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding;Bradford;Analytical Biochemistry,1976

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects;Cancers;2021-04-10

2. Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells;Frontiers in Endocrinology;2020-02-20

3. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms;International Journal of Molecular Sciences;2019-08-13

4. Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas;BIO-PROTOCOL;2018

5. BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas;Scientific Reports;2017-02